Microvascular complications of insulin-dependent diabetes: Risk factors, screening and intervention

Journal of Paediatrics and Child Health

Volumn 32, Issue 1, 1996, Pages 7-9

  Couper, J ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Adolescents; Diabetic neuropathy; Diabetic retinopathy; Insulin dependent diabetes mellitus; Microalbuminuria

Indexed keywords

ADOLESCENT; DIABETES CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; MICROVASCULATURE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SHORT SURVEY; VASCULAR DISEASE;

EID: 0029880760     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb01531.x     Document Type: Short Survey

References (27)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993; 329: 977-86.
2. Couper JJ, Jones TW, Donaghue KC, Clarke CF, Thomsett MJ, Silink M. Position statement of the Australasian Paediatric Endocrine Group. The Diabetes Control and Complications Trial: Implications for children and adolescents. Med. J. Aust. 1995; 162: 369-72.
3. Effect of intensive diabetes treatment on the development and progression of long term complications in adolescents with insulin dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 1994; 125: 177-88.
4. Rudberg S, Ullman E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria - a longitudinal study in children with Type 1 (insulin dependent) diabetes mellitus. Diabetologia 1993; 36: 1309-14.
5. Fairchild JM, Hing SJ, Donaghue KC et al. Prevalence and risk factors for retinopathy in adolescents with Type 1 diabetes. Med. J. Aust. 1994; 160: 757-62.
6. Couper JJ, Staples AJ, Cocciolone R et al. Relationship of smoking and albuminuria in children with insulin dependent diabetes. Diabetic Med. 1994; 11: 666-70.
7. Golden MP, Ingersoll GM, Brack CJ et al. Longitudinal relationship of asymptomatic hypoglycaemia to cognitive function in IDDM. Diabetes Care 1989; 12: 89-93.
8. Rovet JF, Ehrlich RM, Hoppe M. Intellectual deficits associated with early onset of insulin dependent diabetes mellitus in children. Diabetes Care 1987; 10: 510-15.
9. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; I: 1430-2.
10. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent diabetes. N. Engl. J. Med. 1984; 311: 89-93.
11. Messent J, Elliot T, Hill R, Jarrett J, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study. Kidney Int. 1992; 41: 836-9
12. Couper JJ, Daneman D. Microalbuminuria in adolescents with IDDM. Am. J. Dis. Child 1990; 144: 234-7.
13. Couper JJ, Clarke CF, Byrne GB et al. Intermittent microalbuminuria in adolescents with IDDM: Factors predicting progression. J. Paediatr. Child Health 1995; 31: A19.
14. Hansen KW, Christensen CK, Anderson PH, Pedersen MM, Christiansen JS, Mogensen CE. Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int. 1992; 41: 847-54.
15. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. N. Engl. J. Med. 1989; 320: 1161-5.
16. Marre M, Bernadet P, Gallois Y et al. Relationships between angiotensin 1 converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-8.
17. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81-7.
18. Melbourne Diabetic Nephropathy Study Group: Allen TJ, Cooper M, Jerums G et al. Comparison of the effects between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991; 302: 210-16.
19. Couper JJ, Balfe JW, Spino M, Sochett E, Daneman D. Angiotensin converting enzyme inhibitor therapy decreases microalbuminuria in normotensive children with IDDM. J. Pediatr. 1990; 117: 39-45.
20. Davis MD. Diabetic retinopathy: A clinical overview. Diabetes Care 1992; 15: 1844-74.
21. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: A preliminary multicentre trial. N. Engl. J. Med. 1984; 311: 365-72.
22. Klein R, Klein BEK, Moss SE, Davis MD, deMets DL. The Wisconsin Epidemiologic Study of Retinopathy II: Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 1984; 102: 520-6.
23. Donaghue KC, Bonney M, Simpson JM et al. Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabetic Med. 1993; 10: 664-71.
24. Hyllienmark L, Brismar T, Ludvigsson J. Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 1995; 38: 685-92.
25. Vinik AI, Liuzzi FJ, Holland MT, Stansbury KB, LeBeau JM, Colen LB. Diabetic neuropathies. Diabetes Care 1992; 15: 1926-75.
26. Ziegler D, Cicmir I, Wiefels K, Mayer P. Peripheral and autonomic nerve dysfunction in newly diagnosed insulin dependent diabetics. Diabetes 1986; 35: 102A.
27. Vinik AI, Miticevic Z, Pittenger GL. Beyond glycemia. Diabetes Care 1995; 18: 1037-41.